Akebia Therapeutics

This study tests a new drug, vadadustat, taken three times a week, against the usual injected treatment for anemia in people with end-stage kidney disease on dialysis. About 350 adults will participate to see if the drug can safely keep hemoglobin levels in a healthy range. The g…

This study planned to test a once-daily pill called vadadustat for anemia in children with chronic kidney disease. The goal was to see if the drug could safely raise red blood cell levels. However, the study was withdrawn before any participants were enrolled, so no results are a…

This study aimed to test a daily pill called vadadustat for treating anemia in children with chronic kidney disease. The drug was meant to replace standard injections that boost red blood cells. However, the study was withdrawn before any participants were enrolled, so no results…